Introduction
Hepatic vein thrombosis was described first in 1845 and has been extensively studied both as a clue to an undiagnosed condition and as a cause of liver dysfunction. Prothrombotic factors are often found in patients with Budd Chiari syndrome (BCS) [1] . These include myeloproliferative disorders (the most frequent), Factor V Leyden mutation, genetic deficit of protein C and S, hormonal factors (such as pregnancy and the use of oral contraceptives), but also local factors such as diseases associated with abdominal inflammation (inflammatory bowel disease) or intra-abdominal neoplasms.
Two or more hepatic veins must be occluded for the disease to become clinically manifest [2] . As a result of thrombosis, liver congestion appears, followed by increased portal vein pressure and, ultimately, signs of liver fibrosis and liver failure.
The diagnosis is established after confirming the hepatic outflow obstruction, either by ultrasonography (US), computer tomography (CT) scan or magnetic resonance imaging (MRI) [3] .
There are three morphological BCS types described, based on the site of obstruction: truncal type (consisting of obstruction of the inferior vena cava with or without obstruction of the suprahepatic veins), radicular type (consisting of obstruction of the suprahepatic veins) and venoocclusive type (consisting of the obstruction of small centrilobular veins) [4] . Imaging methods may reveal direct or indirect signs of BCS. Direct signs are: visualization of occlusion or extrinsic compression of the suprahepatic veins or inferior vena cava and stagnant or inverted venous flow and the presence of venous collaterals. Indirect signs are: hypertrophy of unaffected liver segments (most frequently the caudate lobe) and atrophy of the affected segments, which leads to the development of regeneration nodules and portal hypertension [5] .
Treatment of BCS is aimed at the underlying disease, complications of portal hypertension and the progression of thrombosis. Several options are available, including anticoagulation and Transjugular Intrahepatic Portosystemic Shunt (TIPS); the selection should be made individually for each patient [5] .
We report several cases of BCS, of various etiologies and clinical evolution, emphasizing the importance of imagistic evaluation. 
Budd Chiari Syndrome associated with myeloproliferative disorders
Case 3: A 29-year-old female patient, with a history of essential thrombocythemia and hepatic vein thrombosis, having TIPS performed 5 years prior to current admission, was admitted for abdominal pain in the upper quadrants. Abdominal US revealed hypertrophy of the caudate lobe and narrowing of the hepatic veins, suggesting BCS and TIPS thrombosis. The thrombosis was confirmed by CT scan, the venous phase revealing impaired blood flow through TIPS, narrowing of the right suprahepatic vein and perfusion disorders in the liver parenchyma (liver ischemia) (fig 3) . Due to the development of liver dysfunction as well as signs of portal hypertension, the patient was evaluated for liver transplantation. Echocardiography and right heart catheterization showed severe pulmonary hypertension (systolic pulmonary artery pressure of 90 mmHg). The patient is currently undergoing treatment with phosphodiesterase inhibitors before being listed for transplantation.
Case 4: A 30-year-old patient, with a history of liver cirrhosis of unknown etiology, with splenectomy and variceal ligation with gastric devascularization at the age of 10, was admitted for further evaluation. The patient denied alcohol abuse or use of any medication. Blood analysis showed negative viral markers, no auto-antibodies, normal serum levels of ceruloplasmin and iron. Abdominal US revealed narrowing of the right hepatic vein. The suspicion of BCS was raised. Abdominal CT scan confirmed the diagnosis, showing hypertrophy of the caudate lobe, no visualization of the suprahepatic veins and signs of portal hypertension (fig 4) . Genetic determinations showed deficit of Factor V Leyden. The patient is currently undergoing anticoagulation therapy with low-molecular weight heparin with favorable out Fig 3. Abdominal ultrasonography, longitudinal scan of the right and caudate lobe, in patient 3, with myeloproliferative disease and thrombosed TIPS: a) in greyscale, chronic alterations in the hepatic veins with two narrowed veins connecting to the inferior vena cava and threadlike aspect of the right hepatic vein (green arrow) can be observed. The caudate lobe was hypertrophied (red arrow) and the portal vein had a normal caliber (blue arrow); b) in Doppler interrogation of TIPS the absence of color Doppler signal and low velocities on pulse Doppler were found, findings suggestive for thrombosis. In the venous phase of the abdominal CT; (c) the TIPS thrombosis, narrowing of the right suprahepatic vein and perfusion lesions in the liver parenchima suggestive for ischemia were described. come. Acenocumarol anticoagulation was not used in this case due to poor control of INR.
Budd Chiari Syndrome after liver resection
Case 5: A 45-year-old female patient, without medical complaints, with a history of multiple liver hydatid cysts for which liver resection was realized 5 years prior to current admission, was evaluated during a routine consult. Abdominal US incidentally revealed stenosis of the left hepatic vein with intrahepatic venous dilatations, permitting the diagnosis of iatrogenic BCS ( fig 5) . As the patient had no medical complaints and no other risk factors for thrombosis, conservative management was chosen, the patient undergoing bi-annual monitoring.
Case 6: A 53-year-old female patient, with history of liver and lung resection for hydatid cysts at the age of 29, chronic liver disease with negative viral and auto-antibodies, was admitted for upper right quadrant abdominal pain and nausea. Clinical evaluation revealed mild hepato-splenomegaly. Blood tests were within normal limits. Abdominal ultrasound showed intrahepatic venous collaterals in the right lobe, inferior vena cava partial occlusion, and hypertrophy of the left and caudate lobe and (fig 6 a-d) , findings confirmed by CT scan (fig 6 e) . Secondary BCS syndrome was diagnosed. As in the previous case, due to the lack of thrombosis risk factors, the patient did not receive anticoagulation and is currently being managed conservatively, with good evolution.
In conclusion, BCS can be associated with a variety of medical conditions; its prompt diagnosis is critical and may change the management of these patients. The Doppler US evaluation of the hepatic veins and the careful assessment of indirect signs of hepatic obstruction are mandatory in patients with risk factors for BCS. Routine US can be successfully performed for follow-up of these patients.
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